# Filing Detail

Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-26-202458
Filing Date
2026-05-04
Accepted
2026-05-04 06:55:03
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B5 | d145684d424b5.htm | 424B5 | 496262
2 | GRAPHIC | g145684g00k09.jpg | GRAPHIC | 682370
3 | GRAPHIC | g145684g84q20.jpg | GRAPHIC | 21413
4 | GRAPHIC | g145684g85f08.jpg | GRAPHIC | 53753
| Complete submission text file | 0001193125-26-202458.txt |  | 1526849

Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-278253 | Film No.: 26934568
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)